Recent News

Award/Ranking

Finnegan Shortlisted in 13 Categories at the 2026 LMG Life Sciences America Awards Finnegan Shortlisted in 13 Categories at the 2026 LMG Life Sciences America Awards

Press Release

Finnegan Recognized as a Leading Firm in the 2025 LMG Life Sciences Americas Rankings Finnegan Recognized as a Leading Firm in the 2025 LMG Life Sciences Americas Rankings

Media Mention

NJ Judge Blocks Sun Pharma from Launching Hair Loss Drug NJ Judge Blocks Sun Pharma from Launching Hair Loss Drug

Award/Ranking

Finnegan Remains a Tier 1 Firm in the 2024 LMG Life Sciences Rankings Finnegan Remains a Tier 1 Firm in the 2024 LMG Life Sciences Rankings

Award/Ranking

Finnegan Shortlisted for 14 LMG Life Sciences 2024 Americas Awards Finnegan Shortlisted for 14 LMG Life Sciences 2024 Americas Awards

Commentary

Fed. Circ. OKs Boston Drug Developer's Patent Win Fed. Circ. OKs Boston Drug Developer's Patent Win

Commentary

Too Many Cooks: Inventorship an Increasing Problem for Patent Counsel Too Many Cooks: Inventorship an Increasing Problem for Patent Counsel

Award/Ranking

Finnegan Upholds Tier 1 Marks in 2023 LMG Life Sciences Rankings Finnegan Upholds Tier 1 Marks in 2023 LMG Life Sciences Rankings

Award/Ranking

Finnegan Shortlisted in 10 Categories in the LMG Life Sciences Awards 2023 Finnegan Shortlisted in 10 Categories in the LMG Life Sciences Awards 2023

Media Mention

Biogen MS Drug Patent Survives Mylan's PTAB Challenge Biogen MS Drug Patent Survives Mylan's PTAB Challenge

Media Mention

PTAB Axes Hair Loss Treatment Patent In Incyte Challenge PTAB Axes Hair Loss Treatment Patent In Incyte Challenge

Press Release

Finnegan Partners Recognized for Commitment to Client Service Finnegan Partners Recognized for Commitment to Client Service